Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70672 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Kouki Tomari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Vancomycin, Glucocorticoids, Anti-Bacterial Agents. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Augmented renal clearance (ARC) can lead to subtherapeutic vancomycin exposure in children. The impact of prior glucocorticoid (GC) exposure on vancomycin pharmacokinetics remains poorly understood. We evaluated the association between GC exposure and vancomycin clearance in paediatric patients.
Methods
We conducted a retrospective cohort study of paediatric patients undergoing vancomycin therapeutic drug monitoring. GC exposure within 2 years was quantified as prednisolone‐equivalent dose. Vancomycin clearance was estimated using the allometrically normalized dose‐to‐level ( D / L ) ratio. Associations were assessed using correlation and multivariable regression adjusted for age, sex, eGFR and inflammatory markers.
Results
Among 245 hospitalized children receiving vancomycin, 157 (64.1%) had prior GC exposure. GC‐exposed children had higher vancomycin D / L ratios ( p = .018). Cumulative GC exposure showed weak positive associations with higher vancomycin clearance (2‐year window: Spearman ρ = .16, p = .013). However, in the fully adjusted model, the association between cumulative GC exposure and D / L ratio was not significant ( β = −.0077 per 10 mg kg −1 , 95% CI −0.026 to 0.010, p = .40). GC exposure was associated with higher odds of subtherapeutic trough concentrations (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
- Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Graduate Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada.
- Child Health Evaluative Services, The SickKids Research Institute, Toronto, Ontario, Canada.
ORCID-Profile: Kouki Tomari, Ruud H J Verstegen, Erin Chung, Shinya Ito, Tamorah R Lewis
Zitieren
APA
Tomari, K., Verstegen, R. H. J., Cruz, C., Chung, E., Azim, A., Ito, S., & Lewis, T. R. (2026). Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70672
Vancouver
Tomari K, Verstegen RHJ, Cruz C, Chung E, Azim A, Ito S, et al. Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70672
BibTeX
@article{Tomari2026,
author = {Tomari, Kouki and Verstegen, Ruud H J and Cruz, Cintia and Chung, Erin and Azim, Aleena and Ito, Shinya and Lewis, Tamorah R},
title = {Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70672}
}
EUVIMED